While scientifically based defaults will remain important and useful when data on CSAF or MOA to refine an assessment are absent or insufficient, assessments should always strive to use these data.
When considering only those patients who had maintained response or stable disease for 84 days, the CBR was 39.1% (CR, 0%; PR, 12.5% [ n = 8]; SD, 26.6% [ n = 17]; insufficient assessments, 23.4% [ n = 15]).
For example, the barrier of "insufficient assessment methods and processes" includes faculty responses that identify the need for clearer assessment strategies so that teaching can be "evidenced and informed by meaningful assessment".
Among concerns were inconsistencies in meeting the needs of children and young people, insufficient assessment of risk and need in some children's cases and some staff not having suitable training.
This suggests that the single parameter of birth weight alone may be an insufficient assessment of intrauterine growth.
Secondly, most included studies based their preprocedural assessment mainly on carotid duplex sonography, which generally gives an insufficient assessment of the vessel anatomy.
This possibly occurred by the insufficient assessment of the septa and mural nodules at CEUS due to the obesity of patient and deep location of lesion.
In a systematic review investigating barriers to adequate cancer pain management, insufficient assessment of pain, patients' reluctance to report pain and poor knowledge of pain management were found to act as barriers for both patients and professionals [ 13].
Failure to scale up may be attributable to insufficient assessment of user groups in context, lack of fit of the innovation with user receptivity, inability to address resistance from stakeholders and inadequate engagement with user groups.
However, possible limitations in the study design in the second study are, among others, insufficient assessment of exposure time to metformin, and the assignment of an arbitrary artificial study entry date.
We suspect that this is primarily because there have been insufficient molecular assessments comparing patients with vs without tumor regression on single agent therapy with monoclonal antibodies, although it remains possible that there are biological reasons instead.
